Glenmark receives approval to market Remogliflozin and Metformin combination drug
The company will commercialise the product under the brand names ‘Remo-M’ and Remozen-M’
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Glenmark Pharmaceuticals
Glenmark Pharma gets US FDA nod for cholesterol lowering drug
The approved products, Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80…
Glenmark Pharma says US FDA has issued CRL for Ryaltris
The CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing…
Glenmark to partner with Novartis to market three respiratory products in Brazil
This arrangement will strengthen Glenmark's respiratory franchise in Brazil Novartis will be responsible to manufacture the…
Glenmark Pharma gets tentative nod from US FDA for acne treatment drug
The drug, Clindamycin Phosphate Foam, 1 per cent, is a generic version of Mylan Pharmaceuticals' Evoclin Foam
Glenmark Pharma receives approval for Indomethacin extended-release capsules
According to IMS health, Indocin SR extended‐release capsules, 75 mg market achieved annual sales of approximately $6.3 million in…
Glenmark records a 29.89 per cent growth in Q4 FY 15-16
India Business grew at 22.52 per cent to Rs 5,397.72 million for the quarter and to Rs 21,092.72 million for the year
Glenmark Pharma’s drugs gets tentative ANDA approval
The approvals are for norethindrone acetate and for adapalene and benzoyl peroxide gel
Glenmark receives US FDA approval for bendamustine hydrochloride injection
It is Glenmark’s first injectable approval in the US
Glenmark settles patent suit with Forest Lab over Savella drug
Glenmark will have the option to market and distribute its milnacipran hydrochloride tablets or an authorised generic version of…